Filling the need for trusted information on health issues…

Trending on kff Enrollment Marketplaces Medicare Advantage

  • your selections
Clear Search

Filter Results

date

Topics

Tags

Content Type

  • results
  • state & global data
  • slides
Study Finds Advertising By Insurers Favors Medicare Advantage Over Stand-Alone Drug Plans

As the marketing period for 2009 Medicare plans nears, the Kaiser Family Foundation Kaiser Family Foundation issued a report analyzing the content and frequency of television, print and radio advertisement for private Medicare plans that ran nationally or in one of three local media markets (Miami/Fort Lauderdale, Fla.; Phoenix, Ariz.;…

Medicare Part D 2008 Data Spotlight: Ten Most Common Brand-Name Drugs

This Medicare Part D Data Spotlight examines the variation in coverage, cost sharing and utilization management tools for the 10 prescriptions most commonly used by Medicare beneficiaries, including treatments for cholesterol, cardiovascular health, osteoporosis, dementia, gastrointestinal reflux and ulcers. It looks at data from the 47 stand-alone prescription drug plans…

Medicare Part D 2008 Data Spotlight: Low-Income Subsidy Plan Availability

This Medicare Part D Data Spotlight focuses on the availability of drug plans for beneficiaries receiving the Part D low-income subsidy in 2008 and changes since 2006. It looks at data from the 47 stand-alone prescription drug plans available nationwide. This is one in a series analyzing key aspects of…

Medicare and the President’s Fiscal Year 2009 Budget Proposal

Medicare and the President’s Fiscal Year 2009 Budget ProposalThis fact sheet summarizes key Medicare-related provisions in the Bush Administration’s fiscal year 2009 budget proposal, as well as additional legislation that responds to the Medicare Trustees’ “Medicare Funding Warning.” Fact Sheet (.pdf)

Medicare Part D 2008 Data Spotlight: Formularies

This spotlight examines the formularies (list of covered drugs) of Medicare stand-alone prescription drug plans in 2008, changes since 2006, and differences in how plans cover brand-name and generic drugs. This is one in a series analyzing key aspects of the 2008 Medicare Part D prescription drug plan choices. It…

Methodology Appendix to the Medicare Part D 2008 Data Spotlights

The Kaiser Family Foundation has also posted an appendix detailing the methodology used in the Medicare Part D 2008 Data Spotlight series. The series analyzes key aspects of the 2008 Medicare Part D prescription drug plan choices. All of the spotlights in this series were prepared by a team of…

Medicare Part D 2008 Data Spotlight: Utilization Management

This spotlight examines three common techniques used by stand-alone prescription drug plans to manage enrollees’ use of formulary drugs, such as quantity limits, prior authorization, and step therapy rules. This is one in a series analyzing key aspects of the 2008 Medicare Part D prescription drug plan choices. It analyzes…

Medicare Part D 2008 Data Spotlights

To better understand changes in the private plans providing drug coverage to Medicare beneficiaries under the program's Part D benefit, the Kaiser Family Foundation is issuing a series of data spotlights analyzing key elements of Medicare's private drug plans. Each spotlight will focus on a key aspect of the drug…

Medicare Part D Data Spotlight: Specialty Tiers

This spotlight focuses on the use of specialty tiers in Medicare Prescription Drug Plans for high-cost and injectible drugs. It finds that the number of plans with specialty tiers has nearly doubled since 2006. It also looks at the drugs assigned to specialty tiers, the beneficiary cost sharing structure, and…